Peter Roelvink
Molecular and Cell Biology
Benitec Biopharma
Australia
Biography
Peter joined Benitec in March 2015 and is responsible for overseeing scientific development in the San Francisco lab. In 1989 Peter received a Doctorate in Agricultural Sciences from the Agricultural University of Wageningen, the Netherlands. After graduation, he completed two post-doctorals at the Agricultural University in the Netherlands and Cornell University, New York on the use of baculoviruses as bio pesticides. Between 1994 and 2003, he researched and developed targeted adenovirus vectors. Dr. Roelvink and his research colleagues were the first to demonstrate delivery of a targeted vector from its native receptor to an artificial receptor. Between 2003 and 2006, he was one of three Benitec senior scientists to design an AAV based short hairpin RNA interference treatment of Hepatitis C. Peter is a (co) inventor on 19 issued US patents that cover RNAi vectors and approaches, targeted delivery of adenoviruses, tissue specific expression using adeno associated viral vectors and the use of adenovirus in vaccine strategy.
Research Interest
Molecular and Cell Biology